Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis

BACKGROUND: Although people are more and more aware of the cardiotoxicity caused by immune checkpoint inhibitors (ICIs) in the treatment of lung cancer, its incidence rate has not been systematically analyzed. This study aims to evaluate the incidence of cardiotoxicity related to the ICI therapies f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiao-Tong, Ge, Nan, Xiang, Zi-Jian, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675058/
https://www.ncbi.nlm.nih.gov/pubmed/36402980
http://dx.doi.org/10.1186/s12935-022-02760-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675058/
https://www.ncbi.nlm.nih.gov/pubmed/36402980
http://dx.doi.org/10.1186/s12935-022-02760-2

Ejemplares similares